The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib dose escalation study of vantictumab (VAN) in combination with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients with previously untreated stage IV pancreatic cancer.
 
S. Lindsey Davis
Speakers' Bureau - Teva (I)
Research Funding - Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Merck (Inst); OncoMed (Inst); Roche (Inst); Senhwa Biosciences (Inst)
 
Dana Backlund Cardin
Consulting or Advisory Role - Merrimack; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Oncolytics (Inst); Roche (Inst); Synta (Inst)
 
Safi Shahda
Consulting or Advisory Role - AstraZeneca; Bayer; Merrimack
Research Funding - Myriad Genetics
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Efrat Dotan
Consulting or Advisory Role - ARMO BioSciences; Boston Biomedical
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Bert O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA
 
Ann M. Kapoun
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - co-author of patents filed at OncoMed (Inst)
Travel, Accommodations, Expenses - OncoMed
 
Robert J. Stagg
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - OncoMed
 
Jordan Berlin
Honoraria - genentech; Nestle health science
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; BeiGene; Celgene; Cornerstone Pharmaceuticals; Eisai; EMD Serono; ERYTECH Pharma; Exelixis; Five Prime Therapeutics; Genentech/Roche; Gritstone Bio; Karyopharm Therapeutics; Symphogen
Research Funding - Bayer (Inst); BeiGene (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Loxo (Inst); Pharmacyclics (Inst); symphogen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; EMD Serono; Genentech/Roche; Nestle health science
Other Relationship - AstraZeneca
 
Wells A. Messersmith
Consulting or Advisory Role - Gilead Sciences; Purdue Pharma; Tanabe Research
Research Funding - Aduro Biotech; Alexo Therapeutics; Immunomedics; OncoMed; Pfizer; Roche/Genentech; Takeda
 
Steven J. Cohen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Genentech; Taiho Pharmaceutical